Report Detail

Request for Sample of this report

Other Middle East and Africa Precision Medicine

  • RnM2881248
    • |
  • 05 February, 2019
    • |
  • Global
    • |
  • 90 Pages
    • |
  • Netscribes
    • |
  • Other

Middle East and Africa Precision Medicine Market

The precision medicine market in the Middle East and Africa region is expected to grow at a significant because the adoption of IoMT and healthcare technologies has picked up over the last few years. Pharmaceuticals and biotech companies are trying to enhance medication and precision medicine solutions in the region Diagnostic companies are trying to improve the healthcare sector by adopting various technologies. The adoption of technologies like new-generation sequencing and gene therapy are creating opportunities for the growth of precision medicine market in the region. According to Netscribes, the Middle East and Africa precision medicine market is projected to expand at a compound annual growth rate (CAGR) of 9.96%, leading to a revenue of USD 2.51 Bn by 2023.

The Middle East and Africa precision medicine market is classified into three primary segments: based on ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies); based on therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases); based on technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics).
Diagnostic companies hold the largest share in the segment for ecosystem players and are also expected to grow at the highest CAGR during the forecasted period of 2018-2023. Rising incidences of cancer globally implies that cancer therapeutics will be sought for its prevention as well treatment, because of which it will have the largest share of the therapeutics segment. Due to technological advancements, big data analytics is expected to grow at the highest CAGR with regard to technologies for precision medicine.

Key growth factors

In the African countries, the rising prevalence of diseases like HIV, malaria, tuberculosis, etc., warrant the use of precision medicine, which will in turn, propel the market. The Middle East population’s ability to afford precision medicine is another factor that can be attributed to its growth. Increasing demand for the customized medicine along with the adoption of technology in the region are driving the growth of precision medicine market.

Threats and key players

In the Middle East and African countries, out-of-pocket spending accounts for nearly half the total health-spending. Thus, many people have health insurance coverage, particularly in rural areas and among those who work in the informal sectors.
African countries have underdeveloped supply chains for medicines and often face challenges in maintaining an adequate medical workforce. One of the most pressing and unique challenges facing African healthcare systems is the shortage of adequately trained healthcare workers because of the lack of training programs, coupled with poor working conditions. These factors can hinder research and development in the precision medicine market.
The major players operating in the Middle East and Africa precision medicine market are Pfizer, Novartis, Teva Pharmaceutical Induistries etc.

What’s covered in the report?

1. Overview of the Middle East and Africa precision medicine market.
2. Market drivers and challenges in the Middle East and Africa precision medicine market.
3. Market trends in the Middle East and Africa precision medicine market.
4. Historical, current and forecasted market size data for the Middle East and Africa precision medicine market segmentation by ecosystem players(pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies) – by revenue (USD Bn).
5. Historical, current and forecasted market size data for the Middle East and Africa precision medicine market segmentation by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases) – by revenue (USD Bn).
6. Historical, current and forecasted market size data for the Middle East and Africa precision medicine market segmentation by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics) - by revenue (USD Bn).
7. Historical, current and forecasted country-wise (UAE and Saudi Arabia) market size data (USD Bn) for the Middle East and Africa precision medicine market and its segmentations by ecosystem players(pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies), by therapeutics(cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases), and by technology(big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics).
8. Analysis of the competitive landscape and profiles of major companies operating in the market.

Why buy?

1. Understand the demand for precision medicine market to determine the viability of the market.
2. Determine the developed and emerging markets where precision medicine market is provided.
3. Identify the challenge areas and address them.
4. Develop strategies based on the drivers, trends and highlights for each of the segments.
5. Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
6. Recognize the key competitors of this market and respond accordingly.
7. Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
8. Define the competitive positioning by comparing the products and services with the key players in the market.

Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com.


Chapter 1: Executive summary

  • 1.1. Market scope and segmentation
  • 1.2. Key questions answered
  • 1.3. Executive summary

Chapter 2: The Middle East and Africa precision medicine market - overview

  • 2.1. Middle East and Africa market overview - market trends, drivers and challenges
  • 2.2. Value chain analysis
  • 2.3. Porter’s Five Forces analysis
  • 2.4. Market size- by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
  • 2.4. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.4. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.4. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.4. d. Revenue from healthcare IT specialists/big data companies- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.5. Market size- by therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
  • 2.5. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.5. b. Revenue from cardiovascular- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.5. c. Revenue from central nervous system - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.5. d. Revenue from psychiatric disorder- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.5. e. Revenue from infectious diseases- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.6. Market size - by technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
  • 2.6. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.6. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.6. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.6. d. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 2.6. e. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 3: The Middle East and Africa precision medicine market- by countries

  • 3.1. The UAE
    • 3.1.1. Market overview- market trends, drivers and challenges
    • 3.1.2. Market size- by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
    • 3.1.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.3. Market size- By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
    • 3.1.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.4. Market size- By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
    • 3.1.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.1.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
  • 3.2. Saudi Arabia
    • 3.2.1. Market overview- market trends, drivers and challenges
    • 3.2.2. Market size- by ecosystem players (pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies, healthcare IT specialists/big data companies)
    • 3.2.2. a. Revenue from pharmaceuticals and biotech companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.2. b. Revenue from clinical laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.2. c. Revenue from diagnostic companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.2. d. Revenue from healthcare IT specialists/big data companies - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.3. Market size- By therapeutics (cancer, cardiovascular, central nervous system, psychiatric disorder, infectious diseases)
    • 3.2.3. a. Revenue from cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.3. b. Revenue from cardiovascular - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.3. c. Revenue from psychiatric disorder - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.3. d. Revenue from infectious diseases - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.4. Market size- By technology (big data analytics, bioinformatics, gene sequencing, pharmacogenomics, companion diagnostics)
    • 3.2.4. a. Revenue from big data analytics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.4. b. Revenue from bioinformatics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.4. c. Revenue from gene sequencing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.4. c. Revenue from pharmacogenomics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
    • 3.2.4. c. Revenue from companion diagnostics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4: Competitive landscape

  • 4.1. Abbott Laboratories
  • 4.1.a. Company snapshot
  • 4.1.b. Product offerings
  • 4.1.c. Growth strategies
  • 4.1.d. Initiatives
  • 4.1.e. Geographical presence
  • 4.1.f. Key numbers
  • 4.2. GE Healthcare
  • 4.2.a. Company snapshot
  • 4.2.b. Product offerings
  • 4.2.c. Growth strategies
  • 4.2.d. Initiatives
  • 4.2.e. Geographical presence
  • 4.2.f. Key numbers
  • 4.3. GlaxoSmithKline (GSK)
  • 4.3.a. Company snapshot
  • 4.3.b. Product offerings
  • 4.3.c. Growth strategies
  • 4.3.d. Initiatives
  • 4.3.e. Geographical presence
  • 4.3.f. Key numbers
  • 4.4. Johnson & Johnson
  • 4.4.a. Company snapshot
  • 4.4.b. Product offerings
  • 4.4.c. Growth strategies
  • 4.4.d. Initiatives
  • 4.4.e. Geographical presence
  • 4.4.f. Key numbers
  • 4.5. Pfizer
  • 4.5.a. Company snapshot
  • 4.5.b. Product offerings
  • 4.5.c. Growth strategies
  • 4.5.d. Initiatives
  • 4.5.e. Geographical presence
  • 4.5.f. Key numbers
  • 4.6. Randox Laboratories
  • 4.6.a. Company snapshot
  • 4.6.b. Product offerings
  • 4.6.c. Growth strategies
  • 4.6.d. Initiatives
  • 4.6.e. Geographical presence
  • 4.6.f. Key numbers
  • 4.7. Almac Group
  • 4.7.a. Company snapshot
  • 4.7.b. Product offerings
  • 4.7.c. Growth strategies
  • 4.7.d. Initiatives
  • 4.7.e. Geographical presence
  • 4.7.f. Key numbers
  • 4.8. Novartis AG
  • 4.8.a. Company snapshot
  • 4.8.b. Product offerings
  • 4.8.c. Growth strategies
  • 4.8.d. Initiatives
  • 4.8.e. Geographical presence
  • 4.8.f. Key numbers
  • 4.9. Teva Pharmaceuticals Limited
  • 4.9.a. Company snapshot
  • 4.9.b. Product offerings
  • 4.9.c. Growth strategies
  • 4.9.d. Initiatives
  • 4.9.e. Geographical presence
  • 4.9.f. Key numbers
  • 4.10. CETICS Healthcare Technologies GmbH
  • 4.10.a. Company snapshot
  • 4.10.b. Product offerings
  • 4.10.c. Growth strategies
  • 4.10.d. Initiatives
  • 4.10.e. Geographical presence
  • 4.10.f. Key numbers

Chapter 5: Conclusion

    Chapter 6: Appendix

    • 6.1. List of tables
    • 6.2. Research methodology
    • 6.3. Assumptions
    • 6.4. About Netscribes Inc.

    Note: The Table of Contents (ToC) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research

    Summary:
    Get latest Market Research Reports on Middle East and Africa Precision Medicine . Industry analysis & Market Report on Middle East and Africa Precision Medicine is a syndicated market report, published as Middle East and Africa Precision Medicine . It is complete Research Study and Industry Analysis of Middle East and Africa Precision Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$2,499.00
    		1,964.21
    		2,361.56
    		387,844.80
    		211,015.56
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo